Skip to main content
Circio Holding ASA logo

Circio Holding ASA — Investor Relations & Filings

Ticker · CRNA ISIN · NO0013033795 LEI · 5967007LIEEXZXFYNS31 OL Professional, scientific and technical activities
Open in API
Filings indexed 167 across all filing types
Latest filing 2025-06-06 Share Issue/Capital Cha…
Country NO Norway
Listing OL CRNA

About Circio Holding ASA

https://www.targovax.com/en/

Circio Holding ASA is a clinical-stage company developing novel medicines based on circular RNA (circRNA) and immunotherapy. The company's core focus is its proprietary circVec platform, a circular RNA expression system designed to enhance the efficacy and durability of gene and cell therapies. Circio's development pipeline is directed towards immuno-oncology, targeting difficult-to-treat solid tumors, and the application of its circRNA technology to address genetic diseases.

Recent filings

Filing Released Lang Actions
Circio Holding ASA: Registration of share capital increase following conversion of convertible bonds
Share Issue/Capital Change Classification · 99% confidence The document explicitly announces the 'Registration of share capital increase following conversion of convertible bonds'. This action directly relates to changes in the company's capital structure (issuance of new shares after debt conversion). This aligns perfectly with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not an earnings release, an annual report, or a general regulatory filing, but a specific corporate action related to financing.
2025-06-06 English
Circio Holding ASA: Minutes from the annual general meeting 2025 - Attachment: Circio_Minutes_from_AGM_05_06_25.pdf
AGM Information Classification · 100% confidence The document is explicitly titled "PROTOKOLL FRA ORDINÆR GENERALFORSAMLING" (MINUTES FROM ANNUAL GENERAL MEETING) and details the proceedings, resolutions passed (e.g., approval of annual accounts, determination of board remuneration), and shareholder representation for a meeting held on June 5, 2025. This directly corresponds to the definition of an Annual General Meeting document. The code for AGM materials is AGM-R.
2025-06-05 English
Circio Holding ASA: Minutes from the annual general meeting 2025
AGM Information Classification · 99% confidence The document explicitly states it contains the "Minutes from the annual general meeting 2025" for Circio Holding ASA. The content confirms the meeting took place and that the minutes are attached/made available. This directly corresponds to the definition of AGM Information (AGM-R). Although the text mentions the minutes are attached, the primary subject matter is the official record of the AGM proceedings, making AGM-R a more specific fit than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS), especially given the explicit title.
2025-06-05 English
Circio Holding ASA: Requested Conversion of Convertible Bonds
Capital/Financing Update Classification · 98% confidence The document explicitly details a request for the conversion of convertible bonds into new shares, resulting in an increase in the company's share capital. This action directly relates to changes in the company's capital structure and financing instruments. This aligns perfectly with the definition of 'Capital/Financing Update' (CAP). It is not a general earnings release (ER), a full annual report (10-K), or a simple announcement of a report (RPA).
2025-06-04 English
Circio presents new and differentiating circVec data and corporate update in live webcast - Attachment: 250528_Circio_Webcast.pdf
Investor Presentation Classification · 98% confidence The document is titled 'R&D and corporate update webcast 28 May 2025' and contains extensive slides detailing scientific progress (circVec platform, AAV gene therapy, LNP delivery), financial milestones, and corporate strategy updates. It is clearly a presentation or update material intended for investors and stakeholders, likely accompanying a webcast. This structure strongly aligns with an Investor Presentation (IP), which typically includes R&D updates, corporate strategy, and financial highlights, often presented in a slide format as seen here. It is not a formal regulatory filing like a 10-K or an ER (which is usually just the initial results announcement). Since it is a detailed presentation, IP is the most appropriate classification.
2025-05-28 English
Circio presents new and differentiating circVec data and corporate update in live webcast
Report Publication Announcement Classification · 99% confidence The document is an announcement detailing new scientific data ('circVec data') and providing a corporate update, including the scheduling of a live webcast presentation. It explicitly mentions that the CEO will discuss the 'upcoming annual general meeting on 5 June 2025' during this webcast. Since the document itself is an announcement about presenting information (data and corporate updates) via a webcast, and it mentions an upcoming AGM, it is most closely related to the materials presented at or in preparation for an AGM, or a general corporate update presentation. However, the primary content is a scientific/corporate update presented via a webcast, which aligns best with an Investor Presentation (IP) or a Call Transcript (CT) if it were the transcript itself. Given that it is an announcement *about* a presentation/webcast, and it mentions the AGM, it could potentially be related to AGM materials (AGM-R) or an Investor Presentation (IP). Since the core purpose is presenting new data and corporate strategy via a live event, Investor Presentation (IP) is a strong fit. However, the mention of the AGM and the format (announcement of a presentation) suggests it might be a precursor or related material. Since it is an announcement of a presentation, and not the presentation itself, and it is not a standard regulatory filing, I will check the definitions. It is not a standard ER, IR, or 10-K. It is an announcement of a presentation of data and corporate updates. This strongly suggests Investor Presentation (IP). If it were solely about the AGM logistics, it would be AGM-R or PSI. Since it is a scientific data update presented live, IP is the best fit among the specific options, as it is a detailed update for investors.
2025-05-28 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.